Junaid Mukhdomi, MD
Interventional Pain Medicine · New Albany, OHNPI 1376075135
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $10,954 of the $17,516 with a category attached, or 62.5%. It is spread thinly across 32 manufacturers, the largest accounting for just 21.8%. Reporting peaked in 2022 at $7,743 and has fallen 85.2% since, to $1,149 in 2025.
Across 301 payments — averaging $58.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Boston Scientific$3K
- Saluda Medical Americas, Inc.$3K
- Medtronic$2K
- Spinal Simplicity, LLC$1K
- Nalu Medical, Inc.$867
- plus $4K from 26 others
What the payments were for
- Travel & lodging$6,56237%
- Food & beverage$10,95463%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 39 | $3,826 |
| Boston Scientific | 75 | $3,033 |
| Saluda Medical Americas, Inc. | 21 | $2,509 |
| Medtronic | 27 | $2,043 |
| Spinal Simplicity, LLC | 16 | $1,168 |
| Nalu Medical, Inc. | 21 | $867 |
| Nevro Corp. | 13 | $831 |
| Stryker | 6 | $559 |
| Foundation Fusion Solutions, LLC | 2 | $499 |
| Vertos Medical, Inc. | 6 | $422 |
| AbbVie | 12 | $327 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $210 |
| Relievant Medsystems, Inc. | 2 | $201 |
| Painteq LLC | 3 | $193 |
| Globus Medical | 7 | $150 |
| SPR Therapeutics, Inc | 3 | $109 |
| Collegium Pharmaceutical, Inc. | 6 | $103 |
| Amgen | 5 | $85 |
| Biotronik NRO, Inc. | 4 | $67 |
| Radius Health, Inc. | 4 | $58 |
| Tersera Therapeutics LLC | 2 | $56 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Intra-sana Laboratories | 1 | $21 |
| Pfizer | 1 | $20 |
| Protega Pharmaceutials Inc | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Zimmer Biomet | 1 | $18 |
| Averitas Pharma Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Vertex | 1 | $14 |
| Convatec Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$3,059
- Evoke SCS$2,026
- Superion Indirect Decompression System$1,083
- HA MINUTEMAN G3-R$919
- INTELLIS ADAPTIVESTIM$521
- Omnia$432
- VANTA ADAPTIVESTIM$424
- Nalu Neurostimulation System$416
- SPINEJACK$407
- mild Device Kit$360
- Intracept$299
- PAINTEQ$164
- SYNCHROMEDII$163
- WaveWriter Alpha Prime 16$150
- SUPERION$145
- TYRX$136
- ETERNA$127
- Proclaim IPG$123
- Evoke$109
- GENERAL PAIN MANAGEMENT$108
How this compares
$17,516 in reported general payments places this provider in the 75th percentile of 67 interventional pain medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tizanidine Hcl | 272 | $3,201 |
| Lidocaine | 22 | $2,588 |
| Duloxetine Hcl | 217 | $2,492 |
| Gabapentin | 75 | $906 |
| Methocarbamol | 54 | $825 |
| Diclofenac Sodium | 75 | $817 |
| Meloxicam | 104 | $311 |
| Nortriptyline Hcl | 35 | $256 |
| Cyclobenzaprine Hcl | 29 | $247 |
| Celecoxib | 17 | $247 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $210 |
| Hydromorphone Hcl | 13 | $83 |
| Methylprednisolone | 18 | $74 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in New Albany
- Marcus HarrisNew Albany$9K
- Daniel PapNew Albany$2K
- Gladstone McDowellColumbus$660K
- Humam AkbikFairfield$116K
- Sara NashiCincinnati$116K
- Jaudat MahmoodKent$97K
- Omar AliSpringfield$67K
- Dustin ReynoldsWesterville$61K
- James OttingToledo$47K
- Mark MalinowskiChillicothe$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.